Recently revised guidelines from the American Cancer Society identify
Prostate Specific Antigen (
PSA) as the most accurate method for early detection of
prostate cancer-superior, even, to
Digital Rectal Exam (
DRE).
While this may sound like good news for men, the American Cancer Society (ACS) is still recommending that DRE should remain a part of the testing process when appropriate. The revised guidelines call for PSA testing and DRE each year beginning at age 50 for men who have a life expectancy of at least 10 years. Men at high risk-those of African descent and/or those with a first-degree relative diagnosed with prostate cancer at a young age-should be tested earlier, at age 45.
Source: Adapted from AACC's Clinical Laboratory News.
On this Site